Genematrix Revises GMAI-02 Phase 1 Expected End Date
Genematrix revised the expected end date for the GMAI-02 domestic Phase 1 trial to August 28, 2028, in a correction filing dated October 27, 2026.
Genematrix revised the expected end date for the GMAI-02 domestic Phase 1 trial to August 28, 2028, in a correction filing dated October 27, 2026.